Geneoscopy: Don Hardison

Geneoscopy has appointed Don Hardison to its strategic advisory board. Hardison has more than 40 years of leadership experience in both emerging and Fortune 500 companies. He most recently served as president and CEO of Biotheranostics, until its acquisition by Hologic in February 2021. Prior to that, Hardison served as president, CEO, and director at Good Start Genetics, and also held the position of president and CEO of Exact Sciences, where he helped oversee the company's initial public offering.